Terms: = Endocrine gland cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Treatment
18 results:
1. Contralateral Low-to-Intermediate Suspicion Nodule Is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma.
Pak SJ; Kwon D; Kim BC; Cho JW; Kim WW; Lee YM; Sung TY; Baek JH; Kim WG; Kim WB; Chung KW
Thyroid; 2023 Nov; 33(11):1339-1348. PubMed ID: 37624735
[No Abstract] [Full Text] [Related]
2. Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination.
Previtali C; Sartoris R; Rebours V; Couvelard A; Cros J; Sauvanet A; Cauchy F; Paradis V; Vilgrain V; Dioguardi Burgio M; Ronot M
Diagn Interv Imaging; 2023; 104(7-8):359-367. PubMed ID: 37061392
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
Abdel-Razeq H; Al-Azzam K; Elemian S; Abu-Fares H; Abu Sheikha A; Bani Hani H; Bater R; Sharaf B; Heald B; Esplin ED; Nielsen SM; Alkyam M; Abujamous L; Al-Attary A
Mol Genet Genomic Med; 2023 Apr; 11(4):e2125. PubMed ID: 36537080
[TBL] [Abstract] [Full Text] [Related]
4. Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up.
Casper AC; Parsons MW; Chipman J; Burt LM; Suneja G; Maurer KA; Gaffney DK
Gynecol Oncol; 2021 Aug; 162(2):454-460. PubMed ID: 34092413
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature.
Chao X; Bi Y; Li L
Orphanet J Rare Dis; 2019 Jun; 14(1):147. PubMed ID: 31217017
[TBL] [Abstract] [Full Text] [Related]
6. Is Gross Total Resection Reasonable in Adults with Craniopharyngiomas with Hypothalamic Involvement?
Apra C; Enachescu C; Lapras V; Raverot G; Jouanneau E
World Neurosurg; 2019 Sep; 129():e803-e811. PubMed ID: 31203080
[TBL] [Abstract] [Full Text] [Related]
7. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy.
Baugh KA; Tran Cao HS; van Buren G; Silberfein EJ; Hsu C; Chai C; Barakat O; Fisher WE; Massarweh NN
Surgery; 2019 Feb; 165(2):307-314. PubMed ID: 30243481
[TBL] [Abstract] [Full Text] [Related]
8. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
[TBL] [Abstract] [Full Text] [Related]
9. Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
George A; Kristeleit R; Rafii S; Michie CO; Bowen R; Michalarea V; van Hagen T; Wong M; Rallis G; Molife LR; Lopez J; Banerji U; Banerjee SN; Gore ME; de Bono JS; Kaye SB; Yap TA
Eur J Cancer; 2017 May; 76():52-59. PubMed ID: 28273485
[TBL] [Abstract] [Full Text] [Related]
10. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract] [Full Text] [Related]
11. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract] [Full Text] [Related]
12. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract] [Full Text] [Related]
13. Laparoscopic distal pancreatectomy: a comparative study.
Tang CN; Tsui KK; Ha JP; Wong DC; Li MK
Hepatogastroenterology; 2007; 54(73):265-71. PubMed ID: 17419274
[TBL] [Abstract] [Full Text] [Related]
14. Thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract] [Full Text] [Related]
15. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract] [Full Text] [Related]
16. Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma.
Decker RA; Elson P; Hogan TF; Citrin DL; Westring DW; Banerjee TK; Gilchrist KW; Horton J
Surgery; 1991 Dec; 110(6):1006-13. PubMed ID: 1745969
[TBL] [Abstract] [Full Text] [Related]
17. The risk of second cancer (SC) in patients treated for testicular seminoma.
Hellbardt A; Mirimanoff RO; Obradovic M; Mermillod B; Paunier JP
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1327-31. PubMed ID: 2115033
[TBL] [Abstract] [Full Text] [Related]
18. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.
Ron D; Powers AC; Pandian MR; Godine JE; Axelrod L
J Clin Endocrinol Metab; 1989 Apr; 68(4):701-6. PubMed ID: 2646313
[TBL] [Abstract] [Full Text] [Related]
